Production (Stage)
Bone Biologics Corporation
BBLG
$4.94
$0.17063.58%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
6/10/2025
-
GuruFocus
6/9/2025
-
TipRanks Financial Blog
6/9/2025
-
The Fly
6/6/2025
-
GuruFocus
6/6/2025
-
GuruFocus
6/6/2025
-
GuruFocus
6/6/2025
-
GuruFocus
6/6/2025
-
The Fly
6/6/2025
-
Business Wire
3/29/2025
-
Ticker Report
12/26/2024
-
Ticker Report
10/23/2024
-
Ticker Report
10/21/2024
-
Business Wire
9/26/2024
-
Zolmax
9/4/2024
-
Business Wire
8/28/2024
-
Ticker Report
8/15/2024
-
Ticker Report
8/14/2024
-
Zolmax
8/13/2024
-
Ticker Report
8/12/2024
-
SeekingAlpha.com: All News
8/12/2024
-
The Fly
8/12/2024
-
InvestorPlace
8/9/2024
-
InvestorPlace
8/2/2024
-
Seeking Alpha - Healthcare
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
--
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Monday, May 12, 2025
Period Date
Monday, March 31, 2025
Next Filing
Week of Aug 4 and 8 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
--
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
781 552 4452
Address
2 Burlington Woods Drive
Burlington, MA 01803
Burlington, MA 01803
Country
Year Founded
Business Description
Sector
Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein. The company’s medical device NELL-1/DBM, an osteopromotive...
more